Catalyst Wire Dossier Catalyst Wire Dossier

Riboflavin-mediated corneal cross-linking

Riboflavin-mediated corneal cross-linking
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Riboflavin-mediated corneal cross-linking, covering 2025-02-03 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Steroids and Cross-linking for Ulcer Treatment [Phase 3]

See pricing